Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Most companies don't survive for decades, much less pay regular dividends for that long. However, some rare corporations can ...

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the ...

The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...

Merck Research Laboratories. “We are grateful to the dedicated community of patients who participated in these studies and are pleased to offer the option of receiving WINREVAIR through the ...

Merck Research Laboratories, said in the release. “We are grateful to the dedicated community of patients who participated in these studies and are pleased to offer the option of receiving Winrevair ...